Answers are grounded in this paper and cite their sources.
Investigates the impact of BCMA on plasma cell survival, indicating its novel role in immunity.
The generation of long-lived antibody-secreting plasma cells is essential for sustained immunity after vaccination or infection. However, the mechanisms driving the formation and long-term survival of these cells are not fully understood. One hypothesis proposes that survival signals for plasma cells are triggered by ligands, including BAFF and APRIL, which interact with cell surface receptors BAFF-R, TACI and BCMA. Previous research in our lab identified BCMA as a plasma cell-specific marker, with its expression level linked to plasma cell maturation. However, some plasma cells, particularly those generated in vitro, do not express Bcma, indicating that additional factors may regulate Bcma’s expression and plasma cell maturation. Although BCMA is not required for plasma cell generation, it has been proposed to be required in maintaining long-lived plasma cells, even though only a single study reported reduced numbers of long-lived plasma cells in BCMA-deficient mice. However, the extensive shedding of murine BCMA from the plasma cell surface raises doubts about its ability to function as a signaling receptor. This thesis aims to 1) understand whether Bcma expression changes during plasma cell maturation and identify factors regulating its induction, and 2) test whether BCMA is necessary for the survival of long-lived plasma cells. To address the first aim, a Blimp1:GFP/BCMA:Tom reporter mouse model was used to monitor plasma cell maturation, as expression of the hallmark transcription factor of plasma cells Blimp1 is followed by Bcma expression. B cells from this model were cultured with fibroblasts in conditions designed to mimic germinal center-like reaction. Additionally, LPS-activated reporter B cells were transferred into B cell-deficient mice to elucidate whether distinct factors, such as time or niche factors, are missing in conventional in vitro cultures to allow terminal plasma cell maturation and induction of BCMA:Tom expression. Notably, BCMA:Tom expression was fully induced in in vitro-stimulated B cells only after adoptive transfer into recipient mice. This highlights the influence of the in vivo microenvironment in facilitating the formation of a mature plasma cell compartment, which was only incompletely mimicked in cell culture conditions. While most CD138+TACI+ antibody secreting cells in vivo are BCMA:Tom+, we observed a subset of BCMA:Tom− present throughout all CD19/B220 plasma cell subpopulations, primarily in the B220+CD19+ plasmablast population but also in the most mature CD19− plasma cells, proposed to include long-lived plasma cells. Given that BCMA is associated with plasma cell maturation, the presence of BCMA:Tom− cells in this group was unexpected. To elucidate the transcriptional differences between BCMA:Tom− and BCMA:Tom+ plasma cells in each of the subpopulations, RNA-sequencing analysis of bulk-sorted cells from the different populations was performed. Transcriptional analysis revealed that induction of Bcma expression marks a distinct step in the successive development of mature plasma cells, with CD19−BCMA+ plasma cells being the most differentiated plasma cells. However, this work also shows that the expression of Bcma, despite being a marker of maturity, is not sufficient to establish longevity, and, therefore, does not serve as a unique marker to identify long-lived plasma cells. For the second aim, two BCMA-deficient mouse models were created to analyze plasma cell survival under prime and prime-boost immunization conditions with two different antigens. In contrast to published data, the numbers of long-lived antigen-specific plasma cells were comparable between BCMA-deficient and wildtype mice after all immunization regimens. In addition, wildtype and BCMA-deficient plasma cells showed comparable transcriptome profiles with no indication for reduced survival signaling. Interestingly, total plasma cell numbers increased after boost immunization in bone marrow and mesenteric lymph nodes of BCMA-deficient mice, indicating that BCMA has no cell intrinsic role in maintaining long-lived plasma cells. Instead, this result suggests that BCMA serves primarily as a soluble decoy receptor for APRIL, playing a role in regulating the plasma cell population by restricting the availability of survival factors. These findings challenge the current understanding and suggest an unrecognized role of BCMA in plasma cell biology. Additionally, they highlight that the mechanistic circuits of the BAFF/APRIL – BAFF-R/TACI/BCMA signaling pathway are only incompletely understood.
No takes yet. Share an insight, caveat, or question.
Shannon Roxana Menzel (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: